| Literature DB >> 31475507 |
Korgün Ökmen1, Burcu Metin Ökmen2.
Abstract
BACKGROUND: The Quadratus Lumborum Block (QLB), which is reported to provide analgesia to the abdominal region, is a newly defined fascial plane block method. The present study aimed to investigate the effect of ultrasound guided anterior QLB on the postoperative pain scores after percutaneous nephrolithotomy.Entities:
Keywords: Fascia; Local anesthetic; Pain; Percutaneous nephrolithotomy; Quadratus lumborum block; Ultrasonography
Mesh:
Substances:
Year: 2019 PMID: 31475507 PMCID: PMC7000288 DOI: 10.4097/kja.19175
Source DB: PubMed Journal: Korean J Anesthesiol ISSN: 2005-6419
Fig. 1.CONSORT diagram. aQLB: anterior quadratus lumborum block, PCA: patient controlled analgesia.
Fig. 2.Anterior quadratus lumborum block. A. (A) convex ultrasound probe was placed on the iliac crest and in the transverse position to the posterior axillary line. Subsequently, the L4 vertebral body at the L4 vertebra level, along with the L4 transverse process, the quadratus lumborum, the erector spinae, and the psoas muscle, were identified as the Shamrock sign. (B) 21 G (100 mm) peripheral nerve block needle was directed towards the thoracolumbar fascia—from the posterior aspect of the transducer to the posteromedial anterolateral direction between the psoas muscle and the quadratus lumborum muscle. (C) Local anesthetic was injected after confirming the site by hydrodissection.
QL: quadratus lumborum muscle, PM: psoas muscle, ES: erector spinae muscle, VB: vertebral body, TP: transverse process, PTLF: posterior thoracolumbar fascia, ATLF: anterior thoracolumbar fascia, MTLF: middle thoracolumbar fascia, TLF: thoracolumbar fascia, White arrow: ultrasound visible block needle, White star: injection site. White circle: local anesthetic spread in the QM.
Comparison of the Demographic Characteristics of the Patients
| Group B (n = 30) | Group C (n = 30) | P value | |
|---|---|---|---|
| Age (yr) | 39.93 ± 12.43 | 40.97 ± 11.62 | 0.741 |
| BMI (kg/m2) | 27.20 ± 4.93 | 26.47 ± 3.78 | 0.522 |
| Gender (M/F) | 7 (23.3%)/23 (76.7%) | 8 (26.7%)/22 (73.3%) | 0.770 |
| Opioid given during surgery (µg) | 131.00 ± 28.49 | 122.53 ± 31.79 | 0.282 |
| Duration of surgery (min) | 55.43 ± 8.71 | 57.87 ± 12.11 | 0.468 |
Values are presented as mean ± SD or number of patients. BMI: body mass index.
Cumulative Morphine Consumption in the First 24 Hours following Surgery
| Morphine consumption (mg) | Group B (n = 30) | Group C (n = 30) | Mean Difference 95% CI | P value |
|---|---|---|---|---|
| 2nd h | 1.15 ± 0.33 | 1.43 ± 0.84 | 0.283 [–0.45, 0.61] | 0.090 |
| 4th h | 1.60 ± 0.67 | 2.37 ± 1.67 | 0.766 [0.49, 0.61] | 0.023 |
| 6th h | 2.82 ± 1.21 | 4.43 ± 2.30 | 1.61 [0.66, 2.56] | 0.001 |
| 12th h | 3.70 ± 1.18 | 6.02 ± 3.47 | 2.31 [0.97, 3.65] | 0.001 |
| 24th h | 6.70 ± 3.47 | 11.92 ± 4.10 | 5.21 [3.25, 7.18] | < 0.001 |
Values are presented as mean ± SD.
Independent sample t-test for the inter-group comparisons.
Comparison of VAS Scores between Groups
| VAS | Group B (n = 30) | Group C (n = 30) | Mean Difference 95% CI | P value |
|---|---|---|---|---|
| 30th min | 0.47 ± 0.73 | 0.93 ± 1.39 | –0.46 [–1.03, 0.106] | 0.109 |
| 2nd h | 0.73 ± 0.87 | 2.83 ± 0.83 | –2.10 [–2.53, 1.66] | < 0.001 |
| 6thh | 0.73 ± 0.78 | 3.00 ± 1.14 | –2.26 [–2.77, 1.75] | < 0.001 |
| 12th h | 1.13 ± 1.01 | 2.60 ± 0.77 | –1.46 [–1.93, 1.00] | < 0.001 |
| 24th h | 0.80 ± 0.89 | 2.90 ± 0.88 | –2.10 [–2.55, 1.64] | < 0.001 |
Values are presented as mean ± SD. VAS: visual analogue scale.
Independent sample t-test for the inter-group comparisons.
Side Effects, Additional Analgesic Requirement, Duration of Surgery (min) and Block Complications
| Group B (n = 30) | Group C (n = 30) | P value | |
|---|---|---|---|
| Side effects | |||
| Nausea and vomiting | 0 | 1 (3.3%) | 0.321 |
| Pruritus | 1 (3.3%) | 1 (3.3%) | 0.694 |
| Bradycardia | - | - | NA |
| Hypotension | - | - | NA |
| Additional analgesic requirement | 0 | 2 (6.7%) | 0.155 |
| Block complications | - | - | NA |
Values are presented as number of patients (%).